The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...

The only jurisdiction with a higher total rate of STIs than Jackson County in 2024 was St. Louis City. Missouri’s rates of ...

Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...

For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...

President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...

Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely ...

Two South Carolina cities face rising STD rates that are among the highest in the U.S. for 2025, a new study shows.

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and ...